Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, CERo Therapeutics Holdings Inc’s stock clocked out at $0.60, up 3.03% from its previous closing price of $0.58. In other words, the price has increased by $3.03 from its previous closing price. On the day, 1.2 million shares were traded.
Ratios:
To gain a deeper understanding of CERO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.73 and its Current Ratio is at 0.73.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 13 ’24 when YK Bioventures Opportunities G sold 2,998,908 shares for $0.06 per share. The transaction valued at 179,934 led to the insider holds 13,005,169 shares of the business.
YK Bioventures Opportunities G sold 1,614,541 shares of CERO for $113,018 on Dec 12 ’24. The 10% Owner now owns 16,004,077 shares after completing the transaction at $0.07 per share. On Dec 11 ’24, another insider, YK Bioventures Opportunities G, who serves as the 10% Owner of the company, sold 1,343,801 shares for $0.08 each. As a result, the insider received 107,504 and left with 17,618,618 shares of the company.
Stock Price History:
Over the past 52 weeks, CERO has reached a high of $117.00, while it has fallen to a 52-week low of $0.53. The 50-Day Moving Average of the stock is -25.77%, while the 200-Day Moving Average is calculated to be -91.37%.
Shares Statistics:
A total of 5.17M shares are outstanding, with a floating share count of 3.93M. Insiders hold about 29.58% of the company’s shares, while institutions hold 12.57% stake in the company.
